Suppr超能文献

假定蛋白SAV1226作为耐甲氧西林/万古霉素感染潜在药物靶点的生物信息学及分子生物学特征分析

Bioinformatics and Molecular Biological Characterization of a Hypothetical Protein SAV1226 as a Potential Drug Target for Methicillin/Vancomycin- Infections.

作者信息

Haag Nichole, Velk Kimberly, McCune Tyler, Wu Chun

机构信息

The Natural Sciences Division, Mount Marty College, Yankton, SD 57078 USA.

Mount Marty College, Yankton, SD 57078 USA, She is now with Yankton High School.

出版信息

World Acad Sci Eng Technol. 2015 Jun;9(6):587-591.

Abstract

Methicillin/multiple-resistant (MRSA) are infectious bacteria that are resistant to common antibiotics. A previous study in our group has identified a hypothetical protein SAV1226 as one of the potential drug targets. In this study, we reported the bioinformatics characterization, as well as cloning, expression, purification and kinetic assays of hypothetical protein SAV1226 from methicillin/vancomycin-resistant Mu50 strain. MALDI-TOF/MS analysis revealed a low degree of structural similarity with known proteins. Kinetic assays demonstrated that hypothetical protein SAV1226 is neither a domain of an ATP dependent dihydroxyacetone kinase nor of a phosphotransferase system (PTS) dihydroxyacetone kinase, suggesting that the function of hypothetical protein SAV1226 might be misannotated on public databases such as UniProt and InterProScan 5.

摘要

耐甲氧西林/多重耐药(MRSA)是对常见抗生素具有抗性的传染性细菌。我们小组之前的一项研究已将假定蛋白SAV1226鉴定为潜在的药物靶点之一。在本研究中,我们报告了来自耐甲氧西林/万古霉素的Mu50菌株的假定蛋白SAV1226的生物信息学特征,以及克隆、表达、纯化和动力学分析。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF/MS)分析显示与已知蛋白的结构相似性较低。动力学分析表明,假定蛋白SAV1226既不是ATP依赖性二羟基丙酮激酶的结构域,也不是磷酸转移酶系统(PTS)二羟基丙酮激酶的结构域,这表明假定蛋白SAV1226的功能可能在诸如UniProt和InterProScan 5等公共数据库中被错误注释。

相似文献

2
Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Comput Biol Chem. 2014 Feb;48:55-63. doi: 10.1016/j.compbiolchem.2013.11.005. Epub 2013 Dec 5.
7
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.
J Antimicrob Chemother. 2002 Feb;49(2):255-60. doi: 10.1093/jac/49.2.255.

本文引用的文献

2
New ways to squash superbugs.
Sci Am. 2009 Jul;301(1):44-51. doi: 10.1038/scientificamerican0709-44.
3
Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
JAMA. 2007 Oct 17;298(15):1763-71. doi: 10.1001/jama.298.15.1763.
5
Mechanisms of antimicrobial resistance in bacteria.
Am J Med. 2006 Jun;119(6 Suppl 1):S3-10; discussion S62-70. doi: 10.1016/j.amjmed.2006.03.011.
6
Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy.
Clin Microbiol Infect. 2005 Jul;11 Suppl 4:33-42. doi: 10.1111/j.1469-0691.2005.01162.x.
7
Antibiotics at the crossroads.
Nature. 2004 Oct 21;431(7011):899-902. doi: 10.1038/431899a.
8
Where will new antibiotics come from?
Nat Rev Microbiol. 2003 Oct;1(1):65-70. doi: 10.1038/nrmicro727.
9
Antibacterials: are the new entries enough to deal with the emerging resistance problems?
Curr Opin Biotechnol. 2003 Dec;14(6):621-6. doi: 10.1016/j.copbio.2003.10.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验